-
Forward Look
Paying a Steep PriceNew laws are pushing health insurers to make oral cancer drugs affordable.
by Betty Russell
-
Q&A
Writing Through ItIn a new book and on her New York Times blog, author Susan Gubar chronicles her experiences living with metastatic cancer.
by Marci A. Landsmann
-
Forward Look
Fueling the Pediatric Cancer PipelineNew efforts are needed to push the pace of drug development.
by Leah Lawrence
-
Yesterday & Today
Who Loves Ya, Baby?Telly Savalas met his match in bladder cancer. Earlier diagnosis and more aggressive treatment might have made a difference.
by Jocelyn Selim
-
Forward Look
It Takes a VillageImproving pediatric cancer care in developing countries
by Leah Lawrence
-
Forward Look
When the Cancer Doctor Gets CancerQ & A with breast surgeon Susan Love on her new role: cancer survivor.
by Betty Russell
-
Survivor Profile
Macho ManCarlos De La Cuesta is redefining manhood after prostate cancer.
by Jocelyn Selim
-
Forward Look
Kids in ActionYoung cancer survivors can benefit from tailored fitness programs.
by Rabiya Tuma
-
Yesterday & Today
The Amazing RideSally Ride's life was cut short by pancreatic cancer. But as the first American woman in space, she still inspires girls to pursue careers in science–and reach for the stars.
by Alexandra Goho
-
Forward Look
Orphan Drugs Still Find a HomeThirty years on, landmark federal legislation continues to benefit patients with rare cancers.
by Emily Gertz
Cancer Talk
Cancer Vaccines Show Promise in Early Trials
While mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona